AUG 10, 2022 11:12 AM PDT

Blood Vessel Disease May Worsen Cognition in Alzheimer's Disease

WRITTEN BY: Zoe Michaud

A new study from a group of Alzheimer’s disease researchers at Augusta University is highlighting the importance of vascular disease in Alzheimer’s disease-associated cognitive decline. The research investigated the impact of microscopic blood vessels on the health of white matter in the brain, the ability of diseased blood vessels to dilate, and the resulting impact on cognition as it relates to Alzheimer’s disease. 

The scientists used data from a longitudinal study called the Adult Changes in Thought Study (or ACT). This study is a joint initiative between the Kaiser Permanente Washington Research Institute and the University of Washington which examines the cognitive health of volunteers in Washington over the age of sixty-five. 

The scientists looked at twenty-eight study participants with varying clinical presentations of vascular disease and Alzheimer’s disease. They used a technique called video microscopy to analyze material from the patients’ brains that was donated post mortem. 

The researchers’ main finding was that in individuals diagnosed with Alzheimer’s disease and vascular disease, there was a higher likelihood that the microscopic blood vessels had an impaired ability to dilate in response to a blood vessel dilator. The impaired ability of blood vessels to dilate was associated with white matter injury on an MRI. 

Dr. Zsolt Bagi, a researchers at Augusta University, says that “the main message of this paper is the mixed pathology as we call it — microvascular disease and Alzheimer’s — is associated with more brain damage, more white matter damage and more inflammation,”

Risk factors for developing vascular disease include diabetes, obesity, and high blood pressure. The researchers note that exercise and controlling levels of blood sugar and blood pressure may be effective in preventing the development of vascular disease that impacts Alzheimer’s disease. 

Understanding the complex interactions of various pathologies on Alzheimer’s disease is instrumental in helping researchers identify tactics to improve cognition or prevent Alzheimer’s disease. “You have some genetic predisposition but people realize that not everybody develops memory decline or cognitive deficits unless something else is coming in,” Bagi says. 

Sources: GeroScience, Mayo Clinic

About the Author
Biology
Zoe (she/her) is a science writer and a scientist working in genomics. She received her B.S. from the University of Connecticut with a focus in Evolutionary Biology. At Labroots, she focuses on writing scientific content related to clinical research and diagnostics.
You May Also Like
SEP 12, 2022
Clinical & Molecular DX
High Blood Pressure Weakens Bone Structure and Can Lead to Osteoporosis
SEP 12, 2022
High Blood Pressure Weakens Bone Structure and Can Lead to Osteoporosis
High blood pressure is a condition that occurs when blood flows through the arteries with more pressure than normal. Hig ...
SEP 22, 2022
Cell & Molecular Biology
Human Protein Crucial to Infection & Disease is Discovered
SEP 22, 2022
Human Protein Crucial to Infection & Disease is Discovered
The pandemic virus SARS-CoV-2 caused many scientists to begin studying infectious disease, in search of ways to stop the ...
SEP 15, 2022
Health & Medicine
Take Micro-breaks to Improve Focus and Boost Wellness
SEP 15, 2022
Take Micro-breaks to Improve Focus and Boost Wellness
A brief break is better than no rest at all and possibly boosts productivity better than a longer break. Micro-breaks, d ...
SEP 16, 2022
Cannabis Sciences
What are sublinguals and how do they work?
SEP 16, 2022
What are sublinguals and how do they work?
Using sublingual cannabis has become a more popular way of consuming THC and CBD. Here's how it works.
SEP 28, 2022
Genetics & Genomics
Microprotein Mutations May Significantly Increase Alzheimer's Risk
SEP 28, 2022
Microprotein Mutations May Significantly Increase Alzheimer's Risk
The mitochondrion, commonly called the powerhouse of the cell, might be one of the best known organelles. This special o ...
OCT 04, 2022
Cancer
The NCI Welcomes First Woman Director: Monica M. Bertagnolli, MD
OCT 04, 2022
The NCI Welcomes First Woman Director: Monica M. Bertagnolli, MD
In August, President Biden announced his intention to appoint Dr. Monica M. Bertagnolli as the newest director of the Na ...
Loading Comments...